Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Shauna Blackmon et al.|Cell|2018Cited by 2k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, Parin Shah et al.|Cell|2018Cited by 1.5k
Targeting TBK1 to overcome resistance to cancer immunotherapyYi Sun, Russell W. Jenkins|Nature|2023Cited by 165
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunityMeng‐Ju Wu, Nabeel Bardeesy, Hiroshi Kondo et al.|Science|2024Cited by 87
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockadeKartik Sehgal, David A. Barbie, Andrew Portell et al.|Journal of Clinical Investigation|2020Cited by 73